Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00854945
First received: March 2, 2009
Last updated: April 16, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)